ROMAINVILLE, France–Parc Biocitech — Cellectis bioresearch, a subsidiary of the genome engineering company Cellectis SA (Paris:ALCLS), announced today that it has launched cGPS® Custom, a new line of kits for targeted gene integration in native cell lines. This is a breakthrough technology that will enable life science researchers to customize their own cell lines. “cGPS® […]

The use of codon optimization in gene synthesis has long been misunderstood. DNA2.0 has cracked the code on optimizing sequence design and has been awarded two US patents covering the technology. DNA2.0’s approach goes beyond codon arrangement, so the company is introducing a new, more accurate category: gene optimization. The algorithm associated with this patent […]

Edinburgh – 11 June 2009 At the Advances in Microarray Technology (AMT) congress in Stockholm, Lab901 unveiled its new ScreenTape R6K product for rapid RNA sample Quality Control (RNA QC). Generating results in as little as 1 minute per sample, ScreenTape R6K extends the use of Lab901’s existing bench-top TapeStation® instrument, which has already started […]

BILLERICA, Mass.–Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the appointment of Ram Ramakrishnan as Vice President, Strategy and Corporate Development. In his new role, Mr. Ramakrishnan is responsible for leading the development of Millipore’s corporate strategy, managing the company’s strategic planning process, […]

OAK BROOK, Ill.–Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced today that its wholly-owned subsidiary, Bio-Bridge Science (HK) Co., Ltd. has entered into a joint venture contract with JR Scientific Inc., a Woodland, California based manufacturer of classical and custom cell culture medium and sera […]

Joint Service Offering to Increase Drug Development Success and the Safety of New Drugs on the Market. Gentronix Limited, a genotoxicity product and services provider, and Apredica, an ADME-Tox contract research laboratory, today announced a strategic alliance to provide drug-discovery support services in the area of predictive toxicology. The objective of the alliance is to […]

Customers can now conveniently access a collection of support services that can be used on a short or long term basis to accelerate their research ST. LOUIS, June 9 — Sigma-Aldrich (Nasdaq: SIAL – News) today announced the launch of its new Services Network designed to provide laboratory services for the pharmaceutical and biotechnology industry. […]

Transformative Transaction to Create the Global Market Leader in the Development and Supply of Research-Grade Custom Peptides RICHMOND, Va.–Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to announce that it has executed an agreement to acquire all of the outstanding shares of GL Biochem (Shanghai) Ltd (“GL Biochem”), a privately owned Shanghai-based chemical company […]

RICHMOND, Va.–Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to provide the following market update reporting on its recently executed term sheet to acquire all of the outstanding shares of GL Biochem (Shanghai) Ltd (“GL Biochem”). 1. CBI MERGER WITH GL BIOCHEM Following CBI’s announcement of June 8, 2009, CBI Management believes that the […]

Max Planck Institute for Molecular Genetics awards GENEART a major contract for the production of genes and gene variants Expected order volume is approximately EUR 300,000 The genes delivered will be used within the Mutanom Project Goal of the Mutanom Project is to research the effects of mutations in the genotype and their relevance for […]